NCT02696707View on ClinicalTrials.gov

An Integrated Consent Model Study to Compare Two Standard of Care Schedules for Monitoring Cardiac Function in Patients Receiving Trastuzumab for Early Stage Breast Cancer

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

May 31, 2020

Study Completion Date

July 31, 2020

Conditions
Breast Cancer
Interventions
PROCEDURE

LVEF 3 month

cardiac evaluation (by either transthoracic echocardiography or MUGA) every 3 months

PROCEDURE

LVEF 4 month

cardiac evaluation (by either transthoracic echocardiography or MUGA) every 4 months

Trial Locations (4)

L3Y 2P9

Southlake Regional Health Centre, Newmarket

K1H 8L6

The Ottawa Hospital, Ottawa

K2H 8L6

The Ottawa Hospital Cancer Centre, Ottawa

P7B 6V4

Thunder Bay Regional Health Sciences Centre, Thunder Bay

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER